Cibc Private Wealth Group, LLC Exact Sciences Corp Transaction History

Cibc Private Wealth Group, LLC

$51.3 Billion
Q1 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,941 shares of EXAS stock, worth $159,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,941

Previous 3,357 12.39%

Holding current value

$159,931

Previous $188,000 32.45%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$43.04 - $58.51 $17,904 - $24,340	-416 Reduced 12.39%	2,941 $127,000
Q4 2024 Feb 12, 2025	SELL	$49.33 - $71.97 $21,014 - $30,659	-426 Reduced 11.26%	3,357 $188,000
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $9,037 - $15,086	-213 Reduced 5.33%	3,783 $257,000
Q2 2024 Aug 09, 2024	SELL	$41.33 - $74.26 $3,058 - $5,495	-74 Reduced 1.82%	3,996 $168,000
Q1 2024 May 10, 2024	BUY	$56.27 - $73.77 $6,752 - $8,852	120 Added 3.04%	4,070 $281,000
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $233,287 - $299,094	3,950 New	3,950 $292,000
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $258,550 - $388,335	3,921 New	3,921 $267,000
Q2 2023 Nov 21, 2023	BUY	$62.68 - $95.05 $139,588 - $211,676	2,227 New	2,227 $209,000
Q2 2023 Aug 10, 2023	BUY	$62.68 - $95.05 $139,588 - $211,676	2,227 New	2,227 $209,000
Q2 2022 Aug 03, 2022	SELL	$35.61 - $76.23 $230,895 - $494,275	-6,484 Reduced 99.54%	30 $1,000
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $14,447 - $20,717	-251 Reduced 3.71%	6,514 $455,000
Q4 2021 Feb 08, 2022	SELL	$72.5 - $100.68 $17.7 Million - $24.6 Million	-244,804 Reduced 97.31%	6,765 $527,000
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $3.4 Million - $4.68 Million	37,700 Added 17.63%	251,569 $24 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $465,396 - $692,032	-4,969 Reduced 2.27%	213,869 $26.6 Million
Q1 2021 May 12, 2021	SELL	$116.57 - $155.01 $1.02 Million - $1.35 Million	-8,718 Reduced 3.83%	218,838 $28.8 Million
Q4 2020 Feb 12, 2021	SELL	$99.61 - $142.12 $430,713 - $614,526	-4,324 Reduced 1.86%	227,556 $30.1 Million
Q3 2020 Nov 03, 2020	BUY	$72.92 - $102.01 $16.9 Million - $23.7 Million	231,880 New	231,880 $23.6 Million
Q3 2020 Oct 29, 2020	SELL	$72.92 - $102.01 $16.7 Million - $23.3 Million	-228,433 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $637,445 - $1.06 Million	-11,434 Reduced 4.77%	228,433 $19.9 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $267,990 - $738,495	-7,071 Reduced 2.86%	239,867 $13.9 Million
Q4 2019 Jan 30, 2020	SELL	$77.66 - $99.74 $701,813 - $901,350	-9,037 Reduced 3.53%	246,938 $22.8 Million
Q3 2019 Oct 16, 2019	SELL	$90.37 - $122.49 $68.3 Million - $92.5 Million	-755,246 Reduced 74.69%	255,975 $23.1 Million
Q2 2019 Jul 31, 2019	SELL	$89.51 - $118.04 $3.42 Million - $4.51 Million	-38,241 Reduced 3.64%	1,011,221 $119 Million
Q1 2019 May 10, 2019	BUY	$61.98 - $96.5 $8.73 Million - $13.6 Million	140,825 Added 15.5%	1,049,462 $90.9 Million
Q4 2018 Feb 05, 2019	SELL	$56.04 - $82.66 $10.7 Million - $15.8 Million	-190,930 Reduced 17.36%	908,637 $57.3 Million
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $365,507 - $610,061	-7,569 Reduced 0.68%	1,099,567 $86.8 Million
Q2 2018 Aug 02, 2018	BUY	$37.84 - $69.96 $18.2 Million - $33.7 Million	481,230 Added 76.89%	1,107,136 $66.2 Million
Q1 2018 May 17, 2018	BUY	$39.82 - $57.53 $20.2 Million - $29.1 Million	506,404 Added 423.76%	625,906 $25.2 Million
Q4 2017 Feb 12, 2018	BUY	$46.49 - $60.51 $5.56 Million - $7.23 Million	119,502	119,502 $6.28 Million

Others Institutions Holding EXAS

# of Institutions

645

Shares Held

157M

Call Options Held

1.74M

Put Options Held

1.56M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.62B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Exact Sciences Corp Transaction History